Important Class Action Deadline for Park Ha Biological Technology Investors Approaching Soon
Deadline Alert for BYAH Investors
September 28, 2026, is a crucial date for investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) who have experienced financial losses due to the company's alleged misrepresentations during its initial public offering (IPO) period. Levi & Korsinsky, LLP has filed a class action lawsuit that centers on claims related to potential violations of the Securities Act and the Securities Exchange Act.
The lawsuit asserts that the registration statement submitted by Park Ha in December 2024 improperly disclosed key details that contributed to a manipulated stock price during the critical IPO phase. Specifically, claims have emerged that the company's public float was intentionally limited to a mere 1,200,000 shares out of a total of 26,200,000 shares, thus enabling a pump-and-dump scheme that caused investors to face massive financial losses when the stock price plummeted from an intraday high of $41.49 to a mere $2.99 within a single day by July 8, 2025. This decline erased more than $1 billion in market capitalization.
Joseph E. Levi, lead attorney for the case, emphasized the importance of the Private Securities Litigation Reform Act (PSLRA), stating, “The PSLRA provides essential protections for investors who may have been harmed by alleged securities violations. Here, the allegations focus not just on what was stated in the prospectus but also on significant omissions that misled potential investors.”
Investors who purchased BYAH shares between December 27, 2024, and July 8, 2025, should evaluate their eligibility for joining this class action lawsuit. The crucial details include the need for documentation of their stock purchase dates, quantities, and any resulting financial losses sustained. Those who sold shares at a loss during this period can still seek recovery. The deadline to file a motion to become the lead plaintiff in this action is September 28, 2026.
Inquiries can be directed to legal representatives via phone or email as provided here: Joseph E. Levi, Esq. can be contacted at (212) 363-7500 or via email at [email protected].
In this kind of lawsuit, the lead plaintiff plays an essential role, typically representing the interests of the entire class of affected investors. While being appointed as the lead plaintiff does not augment individual recovery amounts, it provides significant oversight regarding the direction of the case.
Levi & Korsinsky's expertise in shareholder rights litigation is notable. The firm has succeeded in recovering substantial monetary amounts for investors over the years, placing it consistently among the top practices nationally.
As the deadline approaches, affected BYAH investors are urged to take action promptly to understand their rights and potential remedies under this legal initiative. For anyone impacted by the alleged misrepresentations, this may be an opportunity to seek compensation and justice. With mounting claims against Park Ha Biological Technology, the outcome of this lawsuit could have significant implications for stakeholders involved.
Stay informed and make sure to assess your eligibility before the deadline to ensure your concerns are adequately addressed.
September 28, 2026, is a crucial date for investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) who have experienced financial losses due to the company's alleged misrepresentations during its initial public offering (IPO) period. Levi & Korsinsky, LLP has filed a class action lawsuit that centers on claims related to potential violations of the Securities Act and the Securities Exchange Act.
Overview of the Allegations
The lawsuit asserts that the registration statement submitted by Park Ha in December 2024 improperly disclosed key details that contributed to a manipulated stock price during the critical IPO phase. Specifically, claims have emerged that the company's public float was intentionally limited to a mere 1,200,000 shares out of a total of 26,200,000 shares, thus enabling a pump-and-dump scheme that caused investors to face massive financial losses when the stock price plummeted from an intraday high of $41.49 to a mere $2.99 within a single day by July 8, 2025. This decline erased more than $1 billion in market capitalization.
Joseph E. Levi, lead attorney for the case, emphasized the importance of the Private Securities Litigation Reform Act (PSLRA), stating, “The PSLRA provides essential protections for investors who may have been harmed by alleged securities violations. Here, the allegations focus not just on what was stated in the prospectus but also on significant omissions that misled potential investors.”
Key Details for Affected Investors
Investors who purchased BYAH shares between December 27, 2024, and July 8, 2025, should evaluate their eligibility for joining this class action lawsuit. The crucial details include the need for documentation of their stock purchase dates, quantities, and any resulting financial losses sustained. Those who sold shares at a loss during this period can still seek recovery. The deadline to file a motion to become the lead plaintiff in this action is September 28, 2026.
Inquiries can be directed to legal representatives via phone or email as provided here: Joseph E. Levi, Esq. can be contacted at (212) 363-7500 or via email at [email protected].
The Role of Investors in this Class Action
In this kind of lawsuit, the lead plaintiff plays an essential role, typically representing the interests of the entire class of affected investors. While being appointed as the lead plaintiff does not augment individual recovery amounts, it provides significant oversight regarding the direction of the case.
Levi & Korsinsky's expertise in shareholder rights litigation is notable. The firm has succeeded in recovering substantial monetary amounts for investors over the years, placing it consistently among the top practices nationally.
Conclusion
As the deadline approaches, affected BYAH investors are urged to take action promptly to understand their rights and potential remedies under this legal initiative. For anyone impacted by the alleged misrepresentations, this may be an opportunity to seek compensation and justice. With mounting claims against Park Ha Biological Technology, the outcome of this lawsuit could have significant implications for stakeholders involved.
Stay informed and make sure to assess your eligibility before the deadline to ensure your concerns are adequately addressed.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.